You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Colorcon
Express Scripts
Medtronic
McKesson

Last Updated: May 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Human calcitonin


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Human calcitonin?

Human calcitonin is an investigational drug.

There have been 16 clinical trials for Human calcitonin. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2018.

The most common disease conditions in clinical trials are Osteoporosis, Headache, and Diabetes Mellitus. The leading clinical trial sponsors are Amgen, Novartis, and University of Pittsburgh.

There are ninety-two US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Human calcitonin
TitleSponsorPhase
Alendronate Versus Denosumab in Kidney Transplant PatientsNahda UniversityPhase 2/Phase 3
Alendronate Versus Denosumab in Kidney Transplant PatientsAin Shams UniversityPhase 2/Phase 3
Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine.NovartisPhase 4

See all Human calcitonin clinical trials

Clinical Trial Summary for Human calcitonin

Top disease conditions for Human calcitonin
Top clinical trial sponsors for Human calcitonin

See all Human calcitonin clinical trials

US Patents for Human calcitonin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Human calcitonin   Start Trial Anti-CGRP compositions and use thereof ALDERBIO HOLDINGS LLC (Las Vegas, NV)   Start Trial
Human calcitonin   Start Trial Methods for the expression of peptides and proteins Numaferm GmbH (Duesseldorf, DE)   Start Trial
Human calcitonin   Start Trial Phenylalkylcarboxylic acid delivery agents EMISPHERE TECHNOLOGIES, INC. (Roseland, NJ)   Start Trial
Human calcitonin   Start Trial Anti-CGRP/anti-IL-23 bispecific antibodies and uses thereof Eli Lilly and Company (Indianapolis, IN)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Human calcitonin

Drugname Country Document Number Estimated Expiration Related US Patent
Human calcitonin Argentina 086515 2031-05-20   Start Trial
Human calcitonin Argentina 086516 2031-05-20   Start Trial
Human calcitonin Argentina 087612 2031-05-20   Start Trial
Human calcitonin Australia 2011336470 2030-12-01   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKesson
AstraZeneca
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.